These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 1691357

  • 1. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL, Henningsen NC, Fagher B, Thulin T, Hulthén UL.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [Abstract] [Full Text] [Related]

  • 2. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D, Navis GJ, Donker AJ, de Jong PE.
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study.
    Fagher B, Henningsen N, Hulthén L, Katzman P, Thulin T.
    Eur J Clin Pharmacol; 1990 Oct; 39 Suppl 1():S41-3. PubMed ID: 2261943
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T, Murabayashi S, Takebe K.
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [Abstract] [Full Text] [Related]

  • 5. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M.
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [Abstract] [Full Text] [Related]

  • 6. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE.
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [Abstract] [Full Text] [Related]

  • 7. An overview of the clinical pharmacology of enalapril.
    Davies RO, Gomez HJ, Irvin JD, Walker JF.
    Br J Clin Pharmacol; 1984 Apr; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [Abstract] [Full Text] [Related]

  • 8. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 9. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
    Dukacz SA, Adams MA, Kline RL.
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
    [Abstract] [Full Text] [Related]

  • 10. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP, Bauer JH.
    Am J Kidney Dis; 1988 Jun; 11(6):499-507. PubMed ID: 2837083
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E, Gammaro L, Bedogna V, Tonon M, Giorgetti P, Pica B, Antonini P, Tessitore N, Oldrizzi L, Rugiu C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [Abstract] [Full Text] [Related]

  • 13. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Dec; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 14. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
    Sennesael JJ, Lamote JG, Violet I, Tasse S, Verbeelen DL.
    Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
    [Abstract] [Full Text] [Related]

  • 15. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
    Bauer JH, Sunderrajan S, Reams G.
    Am J Cardiol; 1985 Dec 06; 56(16):62H-67H. PubMed ID: 2933950
    [Abstract] [Full Text] [Related]

  • 16. Effects of verapamil and converting enzyme inhibition on bilateral renal function of two-kidney, one-clip hypertensive rats.
    Ploth DW, Kleeman K, Morrill L, Rademacher R, Jackson CA.
    Clin Sci (Lond); 1987 Jun 06; 72(6):657-67. PubMed ID: 3036414
    [Abstract] [Full Text] [Related]

  • 17. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Acta Med Scand; 1988 Jun 06; 223(2):125-31. PubMed ID: 3279724
    [Abstract] [Full Text] [Related]

  • 18. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Jun 06; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 19. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr 06; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 20. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G.
    Clin Exp Pharmacol Physiol; 2005 Oct 06; 32(10):865-70. PubMed ID: 16173949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.